Fulgent Genetics, Inc. (FLGT) Institutional Ownership

Ownership Summary

Fulgent Genetics, Inc. (NASDAQ:FLGT) has 156 institutional investors that have filed 13F reports for the period ending March 2026.

• These investors collectively held 56.5% of Fulgent Genetics's outstanding shares in March 2026, down from 658163.5% in December 2025.
• They increased total shares held in Fulgent Genetics by 2.69% from last quarter, and the number of investors in FLGT decreased 12.36% annually.
• Of these 156 funds, 77 grew their exposure to Fulgent Genetics, 55 cut back, and 24 maintained positions.
• In total, institutional investors held 17.45Mn shares in Fulgent Genetics as of March 2026, up by 457.93K shares quarter on quarter, and down 267.1K shares year over year.
• BlackRock, Inc. is the top holder of Fulgent Genetics as of March 31, 2026, with 2.77Mn shares representing 8.98% of outstanding stock.
• Leading buyers of Fulgent Genetics shares for the quarter ending March 2026 were VANGUARD CAPITAL MANAGEMENT LLC (880.15K), Invenomic Capital Management LP (610.32K), RTW INVESTMENTS, LP (583.97K), JACOBS LEVY EQUITY MANAGEMENT, INC (356.36K), VANGUARD PORTFOLIO MANAGEMENT LLC (215.85K).
• The largest sellers of Fulgent Genetics for the quarter ending March 2026 were NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (1.52Mn), MILLENNIUM MANAGEMENT LLC (537.56K), Goldman Sachs Group Inc (385.64K), Nuveen, LLC (227.59K), DIMENSIONAL FUND ADVISORS LP (217.35K).
• Per Business Quant, the top 10 investors in FLGT for the quarter ending March 2026 include BlackRock, Inc. (2.77Mn), RTW INVESTMENTS, LP (1.29Mn), ACADIAN ASSET MANAGEMENT LLC (1.23Mn), VANGUARD CAPITAL MANAGEMENT LLC (880.15K), DIMENSIONAL FUND ADVISORS LP (671.66K), Invenomic Capital Management LP (610.32K), GEODE CAPITAL MANAGEMENT, LLC (584.21K), Ameriprise Financial Inc (563.38K), State Street Corp (529.4K), D. E. Shaw & Co., Inc. (486.77K).